Case File №
#VI-2026-0076
Shandong Nuoweiou Medical Technology Co
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | B Good | 5 | 6.4 | 5.4 | 7.7 | 6 Aug 2025 |
| ACE-031 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 3 Jul 2025 |
| Adipotide | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 |
| AHK-CU | X N/A | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 |
| AICAR | X N/A | 1 | 7.2 | 7.2 | 7.2 | 28 Mar 2025 |
| Alprostadil | X N/A | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 |
| AOD9604 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 20 Jun 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 8.3 | 8.3 | 8.3 | 9 Jun 2025 |
| BAM15 | X N/A | 1 | 4.3 | 4.3 | 4.3 | 8 Jul 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 5.9 | 5.9 | 5.9 | 21 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| Crystagen | X N/A | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 |
| Dihexa | X N/A | 1 | 6.7 | 6.7 | 6.7 | 16 Mar 2025 |
| Enclomiphene | X N/A | 1 | 6.1 | 6.1 | 6.1 | 27 Feb 2025 |
| Finasteride | X N/A | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 |
| GHRP-6 Acetate | X N/A | 1 | 6.0 | 6.0 | 6.0 | 6 May 2025 |
| Glutathione | X N/A | 1 | 5.3 | 5.3 | 5.3 | 13 Jun 2025 |
| HMG | X N/A | 1 | 9.3 | 9.3 | 9.3 | 16 Mar 2025 |
| Humanin | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 |
| IGF-1 LR3 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 |
| KPV Oral | X N/A | 1 | 4.0 | 3.2 | 3.2 | 14 Jan 2025 |
| L-Carnitine 500mg | X N/A | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 |
| Minoxidil Oral | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 |
| MOTS-C | X N/A | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| NA Semax Amidate | X N/A | 1 | 7.7 | 7.7 | 7.7 | 17 Dec 2024 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.7 | 4.7 | 4.7 | 16 Mar 2025 |
| Oxytocin Acetate | X N/A | 1 | 7.7 | 7.7 | 7.7 | 13 Feb 2025 |
| P21 | X N/A | 1 | 6.7 | 6.7 | 6.7 | 14 Jan 2025 |
| PEG MGF | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| PNC 27 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 |
| Primobolan E Raw | X N/A | 1 | 8.2 | 8.2 | 8.2 | 24 Apr 2025 |
| PTD-DBM | X N/A | 1 | 5.0 | 5.0 | 5.0 | 27 Feb 2025 |
| T3 (Liothyronine) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 7 May 2025 |
| Test Propionate | X N/A | 1 | 7.3 | 7.3 | 7.3 | 27 Feb 2025 |
| Tirzepatide Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 |
| VIP | X N/A | 1 | 5.8 | 5.8 | 5.8 | 8 Jul 2025 |
| Winstrol Oil | X N/A | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 |
| YK-11 Raw | X N/A | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 |
Exhibit II
Evidence Log
43 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | KPV Oral | 4.1 C | 25mg | 25.6mg | +2.5% | 97.74% | 5d8tws | Lab C | Public |
| 24 May 2026 | Oxytocin Acetate | 8.8 A | 10mg | 11.5mg | +15.0% | 97.07% | hsnfpn | Lab E | Public |
| 24 May 2026 | Tirzepatide Raw | 6.9 A | 100g | 86.0g | -14.0% | 98.39% | rtum1h | Lab B | Public |
| 24 May 2026 | AOD9604 | 8.9 A | 5mg | 6.1mg | +22.4% | 97.78% | c7l2c5 | Lab D | Public |
| 24 May 2026 | Humanin | 8.3 A | 15mg | 16.4mg | +9.4% | 98.85% | 4ynkdg | Lab E | Public |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 15mg | 18.6mg | +23.7% | 95.49% | 84v0wv | Lab F | Public |
| 24 May 2026 | P21 | 7.8 A | 50mg | 52.7mg | +5.4% | 95.93% | vw217h | Lab D | Community |
| 24 May 2026 | PTD-DBM | 7.2 A | 2mg | 1.8mg | -9.3% | 96.21% | mzbqtm | Lab D | Community |
| 23 May 2026 | Aromasin (Exemestane) | 6.1 A | 25mg | 23.4mg | -6.4% | 98.11% | hn4rvs | Lab E | Community |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 C | 5mg | 6.0mg | +20.8% | 96.93% | s5tdu0 | Lab D | Public |
| 23 May 2026 | BAM15 | 4.9 C | 50mg | 48.9mg | -2.2% | 98.95% | ino1fv | Lab F | Public |
| 21 May 2026 | Dihexa | 5.0 B | 20mg | 24.2mg | +20.9% | 95.68% | vf2h59 | Lab G | Public |
| 21 May 2026 | IGF-1 LR3 | 5.7 B | 10mg | 10.8mg | +7.8% | 99.18% | 8g20i9 | Lab G | Public |
| 21 May 2026 | Primobolan E Raw | 9.6 A | 1g | 1.0g | +1.9% | 97.12% | rbi1s4 | Lab E | Public |
| 21 May 2026 | AICAR | 6.0 A | 10mg | 10.3mg | +2.7% | 96.29% | yvqyph | Lab G | Public |
| 21 May 2026 | Glutathione | 5.9 B | 15mg | 17.2mg | +14.5% | 98.84% | l5v32d | Lab B | Public |
| 21 May 2026 | Winstrol Oil | 7.1 A | 250mg/ml | 274.5mg/ml | +9.8% | 96.98% | oumeby | Lab C | Public |
| 17 May 2026 | Alprostadil | 5.8 B | 10mg | 9.1mg | -8.7% | 99.91% | mjinvv | Lab E | Public |
| 17 May 2026 | VIP | 6.1 A | 30mg | 33.3mg | +11.1% | 95.11% | tqep3i | Lab B | Public |
| 29 Jan 2026 | Crystagen | 8.7 A | 2mg | 1.8mg | -10.7% | 95.37% | zx9dt0 | Lab A | Public |
| 29 Jan 2026 | Test Propionate | 5.6 B | 100mg/ml | 97.3mg/ml | -2.7% | 96.46% | q67523 | Lab E | Community |
| 7 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.1 B | 5mg | 5.9mg | +18.7% | 96.78% | sm9e12 | Lab A | Community |
| 7 Jan 2026 | NA Semax Amidate | 7.9 A | 15mg | 15.6mg | +4.1% | 95.00% | g34mpb | Lab A | Community |
| 29 Dec 2025 | AHK-CU | 8.1 A | 5mg | 5.7mg | +14.5% | 97.21% | kle7ux | Lab A | Public |
| 29 Dec 2025 | Enclomiphene | 6.3 A | 25mg | 28.6mg | +14.6% | 95.70% | s568hn | Lab G | Public |
| 29 Dec 2025 | YK-11 Raw | 7.5 A | 500g | 580.2g | +16.0% | 95.51% | dxhrzf | Lab E | Community |
| 12 Dec 2025 | L-Carnitine 500mg | 6.5 A | 300mg/ml | 353.4mg/ml | +17.8% | 97.56% | 6hziws | Lab D | Public |
| 12 Dec 2025 | MENT (Trestolone Acetate) | 5.3 B | 300mg/ml | 315.1mg/ml | +5.0% | 99.42% | 6hijt9 | Lab G | Public |
| 12 Dec 2025 | PNC 27 | 6.9 A | 15mg | 17.1mg | +13.9% | 97.81% | jkt0af | Lab F | Public |
| 5 Dec 2025 | Finasteride | 9.3 A | 50mg | 57.1mg | +14.3% | 99.95% | fa6tjt | Lab D | Public |
| 5 Dec 2025 | MOTS-C | 6.1 A | 5mg | 6.2mg | +23.8% | 96.14% | v0kymw | Lab F | Community |
| 5 Dec 2025 | PEG MGF | 6.4 A | 50mg | 58.9mg | +17.8% | 98.20% | gs9ybc | Lab E | Community |
| 17 Nov 2025 | GHRP-6 Acetate | 6.2 A | 50mg | 49.4mg | -1.2% | 96.94% | h8o405 | Lab D | Public |
| 17 Nov 2025 | Minoxidil Oral | 9.5 A | 25mg | 21.8mg | -12.8% | 95.89% | zr0nnl | Lab F | Community |
| 14 Nov 2025 | Adipotide | 9.3 A | 5mg | 5.3mg | +6.6% | 96.43% | ad7vun | Lab G | Public |
| 5 Nov 2025 | HMG | 9.3 A | 10mg | 11.6mg | +16.0% | 95.44% | 1sgvr6 | Lab D | Community |
| 17 Oct 2025 | ACE-031 | 5.9 B | 10mg | 8.8mg | -12.0% | 97.57% | 82k1hv | Lab C | Community |
| 9 Oct 2025 | Tirzepatide | 7.4 A | 20mg | 20.6mg | +3.0% | 99.67% | (no batch ID) | Lab E | Public |
| 9 Oct 2025 | Tirzepatide | 7.7 A | 15mg | 15mg | 99.77% | (no batch ID) | Lab E | Public | |
| 3 Oct 2025 | T3 (Liothyronine) | 5.1 B | 50mg | 60.6mg | +21.2% | 96.77% | 57y6k5 | Lab E | Community |
| 1 Oct 2025 | Tirzepatide | 5.4 C | 30mg | 35mg | +16.7% | 99.90% | (no batch ID) | Lab G | Public |
| 1 Oct 2025 | Tirzepatide | 5.5 C | 10mg | 11.4mg | +14.0% | 99.80% | (no batch ID) | Lab G | Public |
| 6 Aug 2025 | Tirzepatide | 5.8 C | 10mg | 18.81mg | +88.1% | 99.77% | PH10292624 | Lab F | Public |
— END OF EVIDENCE LOG —